Detection and analysis of apoptosis in peripheral blood cells from breast cancer patients

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 4, 1999, Pages 403-406

  Simao T A ^a,b   Andrada Serpa, M J ^c   Mendonca G A S ^a,c   Marques, D D ^a,b   Braga, M A ^a   Santos, A L S ^a   Amorim, L M F ^a,d   Cardoso, L E B ^a   Carmo, P A O ^c   De Moura Gallo, C V ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Pont Univ Catoca Do Rio Janeiro G   (Brazil)

^c INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^d FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Apoptosis; Breast cancer; Cortisol; Fas system; Peripheral blood cells

Indexed keywords

DNA; HYDROCORTISONE;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; BLOOD; BLOOD CELL; BREAST TUMOR; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

APOPTOSIS; BLOOD CELLS; BREAST NEOPLASMS; DNA; ELECTROPHORESIS, AGAR GEL; HUMANS; HYDROCORTISONE;

EID: 0033113504     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/s0100-879x1999000400004     Document Type: Article

References (11)

1. Nagata S (1997). Apoptosis by death factor. Cell, 88: 355-365.
2. Abbas AK (1996). Die and let live: eliminating dangerous lymphocytes. Cell, 84: 655-657.
3. Meagher LC, Cousin JM, Seckl JR & Haslett C (1996). Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. Journal of Immunology, 156: 4422-4428.
4. Blutler B & Cerami A (1986). Cachetin and tumour necrosis factor as two sides of the same biological coin. Nature, 320: 584-588.
5. Segal-Bendirdjian E & Jacquemin-Sablon A (1996). Résistance au cisplatine d'une lignée de leucémie murine associée à un défaut d'appoptose. Bulletin du Cancer, 83: 371-378.
6. Wyllie AH (1992). Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer and Metastasis Reviews, 11: 95-103.
7. Elston CW & Ellis IO (1991). Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology, 19: 403-410.
8. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH & Nagata S (1996). Faz ligand in human serum. Nature Medicine, 2: 317-322.
9. Strand S, Hofmann WJ, Hug H, Müller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH & Galle PR (1996). Lymphocyte apoptosis induced by CD95 (APO/Fas) ligand expressing tumor cells -a mechanism of immune evasion. Nature Medicine, 2: 1361-1366.
10. Hahne M, Rimoldi D, Schröter M, Romero P, Schreier M, French LE, Scheineder P, Bornand T, Fontana A, Lienard D, Cerottini J-C & Tschopp J (1996). Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science, 274: 1363-1366.
11. Keane MM, Ettenberg SA, Lowrey GA, Russell EK & Lipkowitz S (1996). Fas expression and function in normal and malignant breast cell lines. Cancer Research, 56: 4791-4798.